CURRICULUM VITAE
 
 
Address: Strategy, Science Policy & External Innovation
              Sanofi
              1, avenue Pierre Brossolette
              91385 Chilly-Mazarin Cedex
              France
              Email:guy.griebel@sanofi.com
 
Date of birth: December 18, 1966
Birthplace:    Haguenau (France)
 
Education
 
1987:   DEUG (Diplôme d'Etudes Universitaires et Générales) of Psychology
           University Louis Pasteur (Strasbourg, France)
 
1988:   Licence (Degree) in Psychology, composed of two parts:
             - General and Comparative Psychology 
             - Physiological Psychology 
           University Louis Pasteur
 
1989:   1. Maîtrise (M.Sc.) in Psychology, composed of two parts:
             - Experimental Psychology. Dissertation title: "Anxiolytic, sedative and antiepileptic effects of 
               BW A78U"
             - Organizations of Biological Rhythms. Dissertation title: "Study of the sleep/wake cycle 
               and its neuroendocrinal concomitance"
               University Louis Pasteur
 
           2. Certificate of Neurophysiology (part of M.Sc. in Animal Physiology)
               University Louis Pasteur
 
1990:  DEA (Diplôme d'Etudes Approfondies)in Neurosciences. Dissertation title: "Possible involvement of 
          central phosphodiesterase inhibitors, serotonergic and adenosinergic systems in the modulation of 
          anxious responses in mice"
          University Louis Pasteur
 
1990-1993: Ph.D. at the University Louis Pasteur (with Prof. René Misslin, Laboratoire de Psychophysiologie)
                 Dissertation title: "Serotonergic system and emotional reactivity in rats and in mice:
                 Pharmacological approach". (July 1st, 1993).
 
Research experience:
 
1991: March-May / September-October: PhD student, Behavioral Pharmacology, Hoffmann-La Roche (Basel, Switzerland)
1992: September-November: PhD student, Behavioral Pharmacology, Hoffmann-La Roche
1993-1994: Post-doctoral fellow, Pacific Biomedical Research Center, Békésy Laboratory of Neurobiology (Honolulu, USA)
1995: Post-doctoral fellow, Department of Psychology (Christchurch, New Zealand)
1995-1996: Researcher, Psychopharmacology Department, CNS Research, Synthélabo (Bagneux, France)
1997-2000: Team Leader, Psychopharmacology Department, CNS Research, Synthélabo (Bagneux, France)
2000-2002: Group Leader, Psychopharmacology Department, CNS Research, Sanofi-Synthélabo (Bagneux, France)
2002-2004: Head of Psychopharmacology Department, CNS Research, Sanofi-Synthélabo (Bagneux, France)
2005-2009: Global Head of Psychopharmacology Department, CNS Research, Sanofi-Aventis (Bagneux, France)
2010-2012: Psychiatry Research Expert, Exploratory Unit, Sanofi-Aventis (Chilly-Mazarin, France)
2012-2015: Head Assets Valorization and Opportunities Evaluation, Exploratory Unit, Sanofi (Chilly-Mazarin, France)
2015-: Director Evaluation & Valorization, Evaluation & Expertise Department, Strategy, Science Policy & External Innovation, Sanofi (Chilly-Mazarin, France)
 
 
Member of Scientific Societies: 
Society for Neuroscience (since 1995)
European College of Neuropsychopharmacology (since 2004)
American College of Neuropsychopharmacology (Corporate Representative) (2005-2008), Member (2015-)
American College of Neuropsychopharmacology (Member) (since 2015)
European Behavioral Pharmacology Society (since 2006)
 
Language: French (mother tongue), English and German (both fluent).